Get the Stockscreener App
63.61
3.52%
-2.32
After Hours:
63.84
0.23
+0.36%
Doximity Inc stock is traded at $63.61, with a volume of 1.16M.
It is down -3.52% in the last 24 hours and up +5.82% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
See More
Previous Close:
$65.93
Open:
$65.45
24h Volume:
1.16M
Relative Volume:
0.51
Market Cap:
$8.68B
Revenue:
$550.17M
Net Income/Loss:
$201.35M
P/E Ratio:
63.61
EPS:
1
Net Cash Flow:
$232.07M
1W Performance:
+2.90%
1M Performance:
+5.82%
6M Performance:
-17.04%
1Y Performance:
+76.55%
1-Day Range:
$62.98
$65.72
1-Week Range:
$61.88
$66.13
52-Week Range:
$35.32
$85.21
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
63.61 | 12.20B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
284.35 | 45.86B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
73.08 | 12.82B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
89.93 | 7.77B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.63 | 6.29B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
TriaGen Wealth Management LLC Makes New $450,000 Investment in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity rises on Q1 beat; buys Canadian AI-based clinical reference firm - MSN
Fox Run Management L.L.C. Acquires New Position in Doximity, Inc. $DOCS - MarketBeat
Swiss National Bank Trims Position in Doximity, Inc. $DOCS - MarketBeat
Doximity director Cabral sells $1.27 million in shares - Investing.com
Doximity director Cabral sells $1.27 million in shares By Investing.com - Investing.com UK
Liontrust Investment Partners LLP Purchases New Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Element Capital Management LLC Takes Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
586,863 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by Nuveen LLC - MarketBeat
Charles Schwab Investment Management Inc. Has $45.67 Million Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (DOCS) Soars 14% on Strong Earnings, Merger with AI-Powered Platform - MSN
Why Doximity (DOCS) Is Up 5.3% After Strong Q1 Results and $200M Share Buyback - simplywall.st
Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Deutsche Bank AG - MarketBeat
Doximity Inc. Forms Bullish Flag — Upside AheadJuly 2025 Selloffs & Daily Chart Pattern Signal Reports - classian.co.kr
Doximity’s Earnings Call Highlights Growth and AI Advances - MSN
Lord Abbett & CO. LLC Buys 164,614 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Vanguard Group Inc. Boosts Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Director Regina M. Benjamin Sells 5,000 Shares - MarketBeat
What makes Doximity Inc. stock price move sharplyJuly 2025 EndofMonth & Fast Entry and Exit Trade Plans - sundaytimes.kr
Invesco Ltd. Buys 696,923 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Shares Acquired by LPL Financial LLC - MarketBeat
Doximity (NASDAQ:DOCS) Stock Price Down 6.5% on Insider Selling - MarketBeat
AGF Management Ltd. Invests $11.13 Million in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Can Doximity Inc. Overcome Bearish Sentiment2025 Risk Factors & AI Driven Stock Price Forecasts - newsimpact.co.kr
Doximity Announces Leadership Change with New Appointments - TipRanks
Doximity (DOCS) Gets a Buy from Robert W. Baird - The Globe and Mail
Doximity’s Strong Market Position and AI-Driven Growth Reinforce Buy Rating - TipRanks
We Think Doximity's (NYSE:DOCS) Profit Is Only A Baseline For What They Can Achieve - simplywall.st
Doximity, Inc. (NYSE:DOCS) Q1 2026 Earnings Call Transcript - MSN
Doximity (NASDAQ:DOCS) Stock Price Expected to Rise, Piper Sandler Analyst Says - MarketBeat
Blair William & Co. IL Sells 10,592 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Doximity (NASDAQ:DOCS) Issues Quarterly Earnings Results - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
DigitalOcean, Doximity, Freshworks, Braze, and Teradata Stocks Trade Up, What You Need To Know - TradingView
Doximity (NASDAQ:DOCS) Given New $59.00 Price Target at Canaccord Genuity Group - MarketBeat
Sierra Summit Advisors LLC Purchases New Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (NASDAQ:DOCS) Stock Price Expected to Rise, Raymond James Financial Analyst Says - MarketBeat
DOCS- A Healthcare Play That's on the Move After Beat-and-Raise Quarter - Yahoo Finance
Doximity buys AI clinical reference startup Pathway for $63 million - DOTmed
(08/13/25) DOCS: A Healthcare Play That’s on the Move After Beat-and-Raise - moneyshow.com
Jefferies Financial Group Inc. Sells 13,195 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity acquires AI-powered clinical decision support tool - TechTarget
Doximity (NASDAQ:DOCS) Shares Gap Up on Earnings Beat - MarketBeat
Doximity Buying Pathway In $63 Million Deal - Pulse 2.0
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
1.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):